Article
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2008
French Amy J, Sargent Daniel J, Burgart Lawrence J, Foster Nathan R, Kabat Brian F, Goldberg Richard, Shepherd Lois, Windschitl Harold E, Thibodeau Stephen N
Abstract excerpt
PURPOSE: Colon tumors with defective DNA mismatch repair (dMMR) have a well-characterized phenotype and accounts for approximately 15% to 20% of sporadic colon cancer as well as those colon cancer patients with Lynch syndrome. Although the presence of dMMR seems to be a favorable prognostic marker, data suggest that these patients do not respond as well to adjuvant chemotherapy. EXPERIMENTAL DESIGN: In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
